Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | hypothetical protein | 0.0242694 | 1 | 1 |
Echinococcus granulosus | calcium activated potassium channel variant | 0.01945 | 0.76096 | 0.76096 |
Toxoplasma gondii | macrophage migration inhibitory factor, putative | 0.0156496 | 0.572463 | 0.544438 |
Toxoplasma gondii | kringle domain-containing protein | 0.0242694 | 1 | 1 |
Echinococcus granulosus | tissue type plasminogen activator | 0.0242694 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0156496 | 0.572463 | 0.5 |
Leishmania major | macrophage migration inhibitory factor-like protein | 0.0156496 | 0.572463 | 0.544438 |
Brugia malayi | Kringle domain containing protein | 0.0242694 | 1 | 1 |
Schistosoma mansoni | calcium-activated potassium channel | 0.021395 | 0.85743 | 0.85743 |
Giardia lamblia | Macrophage migration inhibitory factor | 0.0156496 | 0.572463 | 1 |
Echinococcus granulosus | calcium activated potassium channel | 0.021395 | 0.85743 | 0.85743 |
Loa Loa (eye worm) | macrophage migration inhibitory factor 2 | 0.00564276 | 0.0761292 | 0.0761292 |
Trichomonas vaginalis | macrophage migration inhibitory factor, mif, putative | 0.0156496 | 0.572463 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0242694 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0242694 | 1 | 1 |
Loa Loa (eye worm) | macrophage migration inhibitory factor 2 | 0.00564276 | 0.0761292 | 0.0761292 |
Echinococcus multilocularis | tissue type plasminogen activator | 0.0242694 | 1 | 1 |
Entamoeba histolytica | macrophage migration inhibitory factor-like protein | 0.0156496 | 0.572463 | 0.5 |
Plasmodium falciparum | cysteine repeat modular protein 1 | 0.0242694 | 1 | 1 |
Plasmodium falciparum | macrophage migration inhibitory factor | 0.0156496 | 0.572463 | 0.544438 |
Brugia malayi | Protein kinase domain containing protein | 0.0242694 | 1 | 1 |
Loa Loa (eye worm) | macrophage migration inhibitory factor | 0.0156496 | 0.572463 | 0.572463 |
Brugia malayi | Bm-MIF-1, identical | 0.0156496 | 0.572463 | 0.572463 |
Loa Loa (eye worm) | large conductance calcium-activated potassium channel alpha subunit ai | 0.01945 | 0.76096 | 0.76096 |
Loa Loa (eye worm) | TK/ROR protein kinase | 0.0242694 | 1 | 1 |
Leishmania major | macrophage migration inhibitory factor-like protein | 0.0156496 | 0.572463 | 0.544438 |
Echinococcus multilocularis | calcium activated potassium channel | 0.021395 | 0.85743 | 0.85743 |
Plasmodium vivax | macrophage migration inhibitory factor, putative | 0.0156496 | 0.572463 | 0.544438 |
Onchocerca volvulus | 0.0242694 | 1 | 1 | |
Echinococcus multilocularis | potassium large conductance calcium activated | 0.021395 | 0.85743 | 0.85743 |
Plasmodium vivax | cysteine repeat modular protein 1, putative | 0.0242694 | 1 | 1 |
Loa Loa (eye worm) | MaxiK calcium-activated potassium channel | 0.0141018 | 0.495694 | 0.495694 |
Echinococcus granulosus | potassium large conductance calcium activated | 0.021395 | 0.85743 | 0.85743 |
Schistosoma mansoni | calcium-activated potassium channel | 0.00534817 | 0.0615177 | 0.0615177 |
Loa Loa (eye worm) | hypothetical protein | 0.0141018 | 0.495694 | 0.495694 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0242694 | 1 | 1 |
Schistosoma mansoni | calcium-activated potassium channel | 0.01945 | 0.76096 | 0.76096 |
Loa Loa (eye worm) | hypothetical protein | 0.00534817 | 0.0615177 | 0.0615177 |
Echinococcus multilocularis | calcium activated potassium channel variant | 0.01945 | 0.76096 | 0.76096 |
Brugia malayi | Large-conductance calcium-activated potassium channel Slo-1 (KCNMA) alpha subunit. C. elegans slo-1 ortholog | 0.0141018 | 0.495694 | 0.495694 |
Trypanosoma brucei | calcium/potassium channel (CAKC), putative | 0.00534817 | 0.0615177 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | > 3 uM | Concentration required to reduce incorporation of [3H]-TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls | ChEMBL. | 9258370 |
IC50 (functional) | > 3 uM | Concentration required to reduce incorporation of [3H]-TdR in drug-treated cultures of intracellular Leishmania major to 50% of controls | ChEMBL. | 9258370 |
IC50 (functional) | > 20 uM | Concentration required to reduce the growth of human Jurkat cells to 50% of control cultures | ChEMBL. | 9258370 |
IC50 (functional) | > 20 uM | Concentration required to reduce the growth of human Jurkat cells to 50% of control cultures | ChEMBL. | 9258370 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Leishmania major | ChEMBL23 | 9258370 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.